Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Novartis Gets Entresto Counterclaims by Hetero, Torrent Tossed

Sept. 28, 2022, 9:06 PM

Novartis AG convinced a federal judge to dismiss counterclaims by two generic-drug makers seeking judgments that would have allowed them to make copies of Entresto, Novartis’ blockbuster heart-failure drug, more than 10 years before the expiration of three patents.

Judge Richard G. Andrews, in an opinion issued Tuesday in the US District Court for the District of Delaware, granted Novartis’ request, holding that the court lacks subject matter jurisdiction over counterclaims by Hetero Labs Ltd. and Torrent Pharmaceuticals Ltd. The companies sought judgments that the patents either shouldn’t have been issued or aren’t infringed.

Andrews rejected the generic-drug makers’ ...